Open AccessPhosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
Author(s) -
Yatan Pal Singh Balhara,
Siddharth Sarkar,
Rishab Gupta
Publication year - 2015
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.159023
Subject(s) - erectile dysfunction , vardenafil , medicine , tadalafil , sildenafil , meta analysis , cgmp specific phosphodiesterase type 5 , tolerability , diabetes mellitus , placebo , randomized controlled trial , adverse effect , sexual dysfunction , endocrinology , alternative medicine , pathology
Patients with diabetes mellitus frequently experience erectile dysfunction. This systematic review and meta-analysis were conducted to find efficacy and tolerability of phosphodiesterase 5 (PDE5) inhibitors in patients with diabetes mellitus experiencing erectile dysfunction.